Thanks for the information Robert. If management is preparing for another offering, it could explain the lackluster response to the Kite approval. While it is not totally unexpected, I thought they were in a pretty good financial position to prepare for a couple commercial launches.
I agree with most of your points. Volume has certainly tapered off without the institutional support. (I think it was actually Q2-Q3 though) While I agree that short interest and price action in CYRX is fairly normal, many retail investors have experienced manipulation by hedge funds and market markers in many of our microcaps and have a difficult time distinguishing between normal sell-offs and manipulated sell-offs, so they often chalk it all up to manipulation.
I don’t necessarily agree that new big name contracts are necessary to maintain the current ~$8 price, but agree it could languish until the actual revenues roll in from the contracts that have already been signed, and management provides some further insight into reasons for additional funding. It could indicate that more commercialization preparations are needed that have yet to be announced, or they are finally nearing the takeover of logistics handling for their BP customers and need to build out that cold chain area.
Market Data 
Markets 
AI
